- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Photonify names new chief
Former ADAC Labs executive Mohamed S. Elmandjra has taken the helm of Photonify Technologies, developer of a novel noninvasive medical imaging technology. The new president and CEO
Former ADAC Labs executive Mohamed S. Elmandjra has taken the helm of Photonify Technologies, developer of a novel noninvasive medical imaging technology. The new president and CEO of Photonify served ADAC as a senior vice president, as well as general manager of the PET division and vice president of marketing. Before that, Elmandjra worked eight years at GE Medical Systems, where he held various management positions in Europe and the U.S. Elmandjra will also serve on the board of directors for privately held Photonify, which is developing an optical spectroscopy product that may allow quantitative real-time imaging and oxygen mapping.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
